flutamid hormone-resist prostat cancer flutamid time subject respons evalu patient hormone-resist prostat cancer addit patient earli progress decreas pre-treat prostat specif antigen level patient find improv surviv toxic gastrointestin perman discontinu flutamid patient flutamid similar antiandrogen role manag hormone-resist prostat cancer relief subject symptom import treatment goal improv surviv drug manag hormone-resist prostat cancer phase studi effect comparison expens drug 